Genetic Engineering News | Top 10 Clinical Trial Failures of 2013 Genetic Engineering News How it failed: Did not meet primary endpoint of showing a statistically significant increase compared to placebo in disease-free survival in patients at high risk of DLBCL relapse following rituximab-based chemotherapy, in Phase III PRELUDE study. Date ... |
